| P1 |
Adalimumab is equally efficient as infliximab in Ulcerative Colitis but inferior in severe disease, Börje Jonefjäll (Sweden) et al. – Complete documentation |
| P2 |
Beyond the Bowel: Secondary Extraintestinal Findings in IBD Patients Undergoing Comprehensive Ultrasound Assessment, Grigoris Petrousis (Sweden) et al. – Complete documentation |
| P3 |
Differences in pharmacological IBD-treatment between adolescents in pediatric care versus young adults in adult care – a Swedish nationwide register-based cohort study 2008-2024, Erik Florwald (Sweden) et al. – Complete documentation |
| P4 |
Efficacy and safety of mirikizumab treatment in adults ≥60 years with moderately-to-severely active ulcerative colitis, Jonas Halfvarson (Sweden) et al. – Complete documentation |
| P5 |
Factors contributing to fatigue and strategies used to manage fatigue in patients with IBD, Susanna Jäghult (Sweden) et al. – Complete documentation |
| P6 |
Food choices and beliefs in adults with inflammatory bowel disease in Sweden, Sara Andersson (Sweden) et al. – Complete documentation |
| P7 |
Gastrointestinal Tuberculosis: a rare but important differential diagnosis of Crohn’s disease assessed by intestinal ultrasound, Tillmann Raith (Sweden) et al. – Complete documentation |
| P8 |
Guselkumab PK and exposure-response relationships are consistent following IV vs SC induction in CD, Kim Stiberg (Sweden) et al. – Complete documentation |
| P9 |
Health-Related Quality of Life and Psychosocial well-being among Children with Enterostomy – A Scoping Review, Katrín Gudlaugsdóttir Jackson (Sweden) et al. – Complete documentation |
| P10 |
Intestinal Ultrasound in IBD During Pregnancy: Opportunities and Challenges, Mladen Makitan (Sweden) et al. – Complete documentation |
| P11 |
Orismilast for the Treatment of Moderate to Severe Ulcerative Colitis: A Proof of Concept Trial, Trine Velte Honoré (Danmark) et al. – Complete documentation |
| P12 |
Plasma metabolomic-lipidomic profiling identifies distinct molecular signatures and dynamic remodeling in ulcerative colitis, Gülden Bilican (Sweden) et al. – Complete documentation |
| P13 |
Proteomics deconvolution of pediatric IBD, Evgeniya Mickols (Sweden) et al. – Complete documentation |
| P14 |
Relapse rates after stopping anti-TNF therapy in patients with IBD – the STATIC-study, Sofie Haglund (Sweden) et al. – Complete documentation |
| P15 |
Serum metabolite profiling for monitoring disease activity in patients with ulcerative colitis, Alexandra Verdeva (Sweden) et al. – Complete documentation |
| P16 |
Small Intestinal Contrast Ultrasonography for stricture detection in Crohn´s Disease – the Swedish perspective, Mladen Makitan (Sweden) et al. – Complete documentation |
| P17 |
Small intestinal contrast ultrasonography performs equally well as MR enterography in Crohn´s disease activity assessment, Mladen Makitan (Sweden) et al. – Complete documentation |
| P18 |
Tofacitinib dose modifications in refractory ulcerative colitis – a Danish multicentre real-world cohort study, Hina Sajid Mirza and Maria Bassam Mati Toma (Denmark) et al. – Complete documentation |
